How does Malaysia benefit from the vaccine deal with China?

Question

Accepted Answer

Malaysia to Receive Priority Access to Chinese-Developed Covid-19 Vaccines

Malaysia will benefit from priority access to Covid-19 vaccines developed by China, alongside knowledge sharing and expertise. This agreement aims to advance scientific and technological capabilities for vaccine development in both nations. The initial phase of this cooperation is set to last for five years.
Priority Access to Vaccines

Under the terms of the agreement, Malaysia is guaranteed preferential access to any Covid-19 vaccines that are successfully developed by China. This provision ensures that Malaysia will be among the first to receive these crucial medical resources.
Knowledge Sharing and Expertise Exchange

The deal facilitates a robust exchange of knowledge and expertise between Malaysia and China concerning vaccine development. This collaborative aspect is designed to foster mutual learning and enhance the overall understanding of vaccine research and production.
Advancing Scientific and Technological Capabilities

A key objective of the agreement is to promote the advancement of scientific and technological capabilities in both countries. This includes fostering an environment that supports and accelerates the progress of vaccine development initiatives.

Reading history

Hide →

This history is cleared when the page is closed.

How does Malaysia benefit from the vaccine deal with China?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends